Feature

MOBILion trailblazing next-gen separation science to reveal what others leave unseen

Closely-held MOBILion Systems is redefining analytical characterization through its next-generation separation science platform that is integrated with high-resolution mass spectrometry to achieve unprecedented...

February 4, 2025

Feature

VICO addressing severe neurological diseases at the source with RNA modulating therapies

Closely-held VICO Therapeutics is developing antisense oligonucleotide (ASO) RNA modulating therapies for patients with severe genetic neurological diseases, including Huntington’s disease (HD) and spinocerebellar...

January 21, 2025

Feature

ROMTech advancing postoperative rehabilitation with unparalleled patient outcomes

Closely-held ROMTech is combining cutting-edge innovation with advanced telemedicine technology, transforming rehabilitation, diagnostics, facilitating seamless remote patient-physician connections for at-home...

January 14, 2025

Feature

IMUNON harmonizing life’s blueprint with immune system through DNA-based therapies

IMUNON (NASDAQ:IMNN) is advancing a distinctive approach to treating of some of the world’s most challenging diseases, leveraging a portfolio of proprietary immunology and DNA-based platforms that harness the body’s...

January 7, 2025

NEWS

Firefly congratulates company advisor, Dr. Christopher Wilson, on UW Faculty of Engineering Award for his work on superconducting quantum electronics

Fennec unveils PEDMARQSI in Germany for cisplatin-induced hearing loss in children

AIM addresses avian flu with follow-up clinical study of Ampligen and FluMist combo

Lively X discussion about the clinical potential of Perimeter’s AI-driven, wide field OCT margin visualization technology during breast cancer surgeries helps drive stock

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

MOBILion trailblazing next-gen separation science to reveal what others leave unseen

VICO addressing severe neurological diseases at the source with RNA modulating therapies

ROMTech advancing postoperative rehabilitation with unparalleled patient outcomes

IMUNON harmonizing life’s blueprint with immune system through DNA-based therapies

NEWS

Firefly congratulates company advisor, Dr. Christopher Wilson, on UW Faculty of Engineering Award for his work on superconducting quantum electronics

Fennec unveils PEDMARQSI in Germany for cisplatin-induced hearing loss in children

AIM addresses avian flu with follow-up clinical study of Ampligen and FluMist combo

Lively X discussion about the clinical potential of Perimeter’s AI-driven, wide field OCT margin visualization technology during breast cancer surgeries helps drive stock

Pyxis initiates new combination trial; expands existing monotherapy trial

Therma Bright adds Steve Raysely to advisory board

Tonix names Siobhan Fogarty as CTO

uniQure completes enrollment for Phase 1/2a trial of gene therapy in Fabry disease

Vanda and Anaptys ink licencing agreement for commercialization of imsidolimab in GPP

Just a few of the companies we’ve highlighted along the way

General

More